Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.122ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.122ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.122ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.122NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAJORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAJENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAJNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.431ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.431ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.431ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.431NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.168ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.168ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.168ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.168NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Q.6 (Alpha)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Q.6 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.6 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.6 (Alpha)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
AZ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.97ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.97ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.97ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.97NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.59ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
B.1.1.59ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.59NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.67ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.67NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.277ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DN.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used